Jnj competitors.

Johnson and Johnson Competitors Results; JNJ Competitors Stock Performance; JNJ Competitors Growth Rates; JNJ Workforce Efficiency at the Competitors; JNJ Competitors Efficiency; JNJ Competitors Management Effectiveness; JNJ Competitors Valuation; Customers & Markets. Johnson and Johnson Customers Demand; JNJ …

Jnj competitors. Things To Know About Jnj competitors.

Johnson & Johnson's top competitors include Pfizer, Novartis and Merck. Unlock 18 more competitors → Select to follow all companies RANK COMPANY CEO CEO RATING EMPLOYEES FUNDING REVENUE Joaquin Duato Chairman & CEO 77/100 152,700 $0 $120.1B 1 Albert Bourla Chairman & CEO 76/100 83,000 - - $77.9B 2 Vasant Narasimhan CEO 84/100 103,000 - - $51B 3May 17, 2023 · We believe Bristol Myers Squibb stock (NYSE: BMY) is a better pick than its industry peer, Johnson & Johnson (NYSE: JNJ). J&J trades at a higher valuation of 4.4x trailing revenues, compared to 3 ... Johnson And Johnson shares improved by 5.27 % during the preceding 30 days , meanwhile, JNJ shares improved by 3.46% over the course of the last five trading days. Johnson And Johnson shares trade only 8% above its 52 week low.Nov 30, 2023 · Contact Investor Relations. Questions? Please contact us: 1-800-950-5089 [email protected]. Dec 3, 2023 · Johnson & Johnson main competitors are AbbVie, Bristol-Myers Squibb, and Eli Lilly and Company. Competitor Summary. See how Johnson & Johnson compares to its main competitors: Merck has the most employees (74,000). Employees at AbbVie earn more than most of the competitors, with an average yearly salary of $107,969.

JNJ Company Profile >> Back to JNJ Fundamentals at a Glance >> Back to JNJ Growth Comparisons Annual Revenue Growth Comment Johnson And Johnson's Annual Revenue for the fiscal year ended 2022, increased by 1.25% to $94,943.00 millions, from $93,775.00 millions achieved a year ago.JNJ Company Profile >> Back to JNJ Fundamentals at a Glance >> Back to JNJ Growth Comparisons Annual Capital Expenditures Growth Comment Johnson And Johnson's Annual Capital Expenditures for the fiscal year ended 2022, increased by 9.78% to $4,009.00 millions, from $3,652.00 millions achieved a year ago.JNJ Sales vs. its Competitors Q3 2023. Comparing the current results to its competitors, Johnson And Johnson reported Revenue decrease in the 3 quarter 2023 year on year by -10.26 %, despite the revenue increase by most of its competitors of 4.83 %, recorded in the same quarter. • List of JNJ Competitors.

Johnson And Johnson OHLC Stock Charts, Monthly, Stock Quotes - CSIMarketIn the Q3, Johnson And Johnson's corporate clients experienced a decline by -14.12 % in their costs of revenue, compared to a year ago, sequentially costs of revenue were trimmed by -7.17 %. During the corresponding time, Johnson And Johnson revenue deteriorated by -10.26 % year on year, sequentially revenue fell by -16.37 %.

Nov 12, 2021 ... ... rivals. image A French research-and-development lab for Johnson & Johnson in 2017. Photo: CHARLY TRIBALLEAU/AFP/Getty Images. The new company ...When it comes to plasma donation, choosing the right center is crucial. Grifols, a leading global healthcare company, is renowned for its state-of-the-art plasma donation centers. Another aspect that sets Grifols apart from its competitors ...Moderna's Business Segments. Moderna operates as a single business segment focused on the discovery, development, and commercialization of mRNA medicines. The company provides a breakdown of this ...www.jnj.com: Cheif Executive Officer: Alex Gorsky: Annual Sales Volume (2013) 71.3 Billion: Total Number of Employees: 128,100: Primary SIC Code: 2834 (Pharmaceutical Preparations) Primary NAICS Code: ... Competitors will follow Johnson and Johnson into the natural remedy options .

Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey. Corporate Governance. Johnson & Johnson’s ISS Governance QualityScore as of November 28, 2023 is 4.

Johnson & Johnson’s Threats. Stiff Competition; From Reckitt Benckiser to Unilever, Procter and Gamble, Abbott, and many more, the large number of strong global players competing against Johnson & Johnson threatens profitability. If stiff competition stiffens further, Johnson & Johnson will lose a substantial portion of its market share.

Johnson And Johnson's Current Key Valuation Ratios, PE, PB, PCF, PS, compare to Major Pharmaceutical Preparations Industry and Healthcare SectorSaturday afternoon JNJ Competition Registration Closes: 1:00 – 2:00pm: Novice ProAm Routines: 2:00 – 3:00pm: Two Step JNJ (Newcomer, Novice, Intermediate, Advanced) Prelim & Finals: 3:00 – 5:30pm: West Coast Swing JNJ {Masters (Novice & Open), Newcomer, Novice, Intermediate, Advanced} Prelims and Semis (if needed)Johnson & Johnson main competitors are AbbVie, Bristol-Myers Squibb, and Eli Lilly and Company. Competitor Summary. See how Johnson & Johnson compares to its main competitors: Merck has the most employees (74,000). Employees at AbbVie earn more than most of the competitors, with an average yearly salary of $107,969.Ticker Symbol: JNJ Type: Public Annual Revenue (Dec 2019): $82.06 Billion ... Stiff Competition; From Reckitt Benckiser to Unilever, Procter and Gamble, Abbott, and many more, the large number of strong global players competing against Johnson & Johnson threatens profitability.Nov 12, 2021 · New Consumer Health Company would be a Global Leader with Iconic Brands and Products that Touch Over One Billion Lives Every Day Johnson & Johnson would Remain a Global Leader in Healthcare, Focused on Major Unmet Medical Needs and Materially Advancing Standard of Care through Biopharmaceutical and Medical Device Innovation and Technology Separation Designed to Enhance Operational Performance ...

Johnson And Johnson' Executive Officers and mambers of the Board - CSIMarketJohnson & Johnson main competitors are AbbVie, Bristol-Myers Squibb, and Eli Lilly and Company. Competitor Summary. See how Johnson & Johnson compares to its main competitors: Merck has the most employees (74,000). Employees at AbbVie earn more than most of the competitors, with an average yearly salary of $107,969.JNJ’s revenue and EBITDA have grown at respective CAGRs of 6.7% and 8.2% over the past three years. The company’s normalized net income has increased at a CAGR of 11.9% over the same period.Competitors of Microsoft include Apple, Google and Oracle, as of 2014. Microsoft’s annual revenues, at more than $86 billion, are higher than Google and Oracle but lower than Apple.Free essays, homework help, flashcards, research papers, book reports, term papers, history, science, politics

“Being a scrappy startup, it’s funny to see some of our designers forklift once in a while,” chuckles Chieh Huang, CEO of Boxed. Unlike most of Silicon Valley, which seems obsessed with multi-billion-dollar valuations for whatever ephemera ...

Price Ratios. Other Ratios. Other Metrics. Income Statement. Balance Sheet. Cash Flow Statement. Key Financial Ratios. View Annual Reports. Ten years of annual and quarterly financial ratios and margins for analysis of Johnson & Johnson (JNJ).Nov 12, 2021 ... ... rivals. image A French research-and-development lab for Johnson & Johnson in 2017. Photo: CHARLY TRIBALLEAU/AFP/Getty Images. The new company ...JNJ Company Profile >> Back to JNJ Fundamentals at a Glance >> Back to JNJ Growth Comparisons Annual Capital Expenditures Growth Comment Johnson And Johnson's Annual Capital Expenditures for the fiscal year ended 2022, increased by 9.78% to $4,009.00 millions, from $3,652.00 millions achieved a year ago.NEW BRUNSWICK, N.J.--(BUSINESS WIRE)-- Johnson & Johnson …Johnson & Johnson has 5 employees across 77 locations and $94.94 b in annual revenue in FY 2022. See insights on Johnson & Johnson including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.Apr 1, 2023 ... Johnson & Johnson has many competitors. They include Procter & Gamble in the Consumer Health sector and Stryker Corporation in the MedTech ...MedTech. Johnson & Johnson MedTech innovates at the intersection of biology and technology. With a focus on treating with pinpoint precision in the hardest-to-reach parts of the body, restoring anatomy and reimagining healing, our portfolio of smarter, less invasive, more personalized treatments is addressing the most complex diseases.Johnson and Johnson Divisions Annual Report. PROCRIT. 1.67 %. of total Revenue. RISPERDAL. 1.6 %. of total Revenue.Johnson & Johnson (J&J) is an American multinational, pharmaceutical, and medical …Johnson & Johnson’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News - Owler Company Profile 37,833 Followers on Owler Johnson & Johnson is a New Jersey-based firm that engages in research, manufacturing and sale of healthcare products including consumer, pharmaceutical and medical devices... Read more

Nov 30, 2023 · The average twelve-month price prediction for Johnson & Johnson is $169.19 with a high price target of $215.00 and a low price target of $52.00. Learn more on JNJ's analyst rating history. Do Wall Street analysts like Johnson & Johnson more than its competitors?

Comparison Analysis Based on SEC Data. Company Name. Johnson & Johnson. Industry (SIC) 2834 - Pharmaceutical Preparations. Revenue in 2022. $94,943 million (ranked #2 out of 645 companies in the industry) Assets as of 12/31/2022. $187,378 million (ranked #2)

Competitive benchmarking is a useful tool for understanding where you can go next with your , and to see where you could be servicing your customers more effectively. It can help you see why your audience might choose a competitor over you, and work on strategies to attract them to your offering instead.Nov 30, 2023 · Contact Investor Relations. Questions? Please contact us: 1-800-950-5089 [email protected]. View the latest JNJ earnings date, analysts forecasts, earnings history, and conference call transcripts ... Enter your email address below to receive the latest news and analysts' ratings for Johnson & …Analysis of Johnson & Johnson 2021. Johnson & Johnson is a famous multinational corporation that manufactures and markets pharmaceuticals, medical devices, and consumer packaged goods. The company's core focus is to develop products related to human health and well-being. In this effort, the company, through its subsidiaries, operates over 120 ...JNJ had done something similar in previous disputes so I knew it was coming down the pike. Limiting the financial burden is a priority. Otherwise, it's open ended and you are like BP who paid $71B ...Johnson & Johnson (JNJ) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends, ratings.Porter’s Five Forces Analysis of Johnson & Johnson covers the company’s competitive landscape as well as the factors affecting its sector. The analysis focuses on measuring the company’s position based on forces like threat of new entrants, threat of substitutes, bargaining power of buyers, bargaining power of suppliers and competitive rivalry.JNJ still faces considerable litigation, regulatory, and competitive risks. The yield, earnings multiple, and earnings per share growth outlook provide a decent total return outlook but not ...Porter’s Five Forces Analysis of Johnson & Johnson covers the company’s competitive landscape as well as the factors affecting its sector. The analysis focuses on measuring the company’s position based on forces like threat of new entrants, threat of substitutes, bargaining power of buyers, bargaining power of suppliers and competitive rivalry.

144,500+. Annual Revenue. $93.77 billion (FY 2021) Website. www.jnj.com. James Wood Johnson, Edward Mead Johnson, and Robert Wood Johnson founded J&J as a family business to serve people with healthcare products. After 130 years, J&J is now one of the leading healthcare industry companies. With over 120,000 employees in the company, J&J is ...In the competitive world of technology, few companies have managed to maintain their dominance as successfully as Microsoft. With its innovative products and strategic business moves, Microsoft has consistently stayed ahead of its competito...Tech Media Success Video Johnson & Johnson (NYSE:JNJ) 158.39 Delayed Data As of …Instagram:https://instagram. best futures prop firmsis chargepoint a good stock to buyrobin hood stockmost sold product ever May 7, 2018 ... ... Johnson & Johnson top competitors; 10. Competitive Advantage ... When moving into a new geographical location, JnJ is always fallen subject to ... should i buy lucid stockprice of a maybach mercedes J&J stock price quote (NYSE: JNJ), historical charts, related news, stock analyst insights and more to help you make the right investing decisions. vanguard intermediate term bond etf Johnson And Johnson' Executive Officers and mambers of the Board - CSIMarketIn today’s fast-paced world, online shopping has become the go-to choice for many consumers. With the convenience of browsing and purchasing products from the comfort of their homes, shoppers are increasingly turning to online retailers.